Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone

Background: A systemic immune-inflammation index (SII) based on neutrophil (N), lymphocyte (L), and platelet (P) counts has shown a prognostic impact in several solid tumors. The aim of this study is to evaluate the prognostic role of SII in metastatic castration-resistant prostate cancer (mCRPC) pa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Lolli, Cristian, Caffo, Orazio, Scarpi, Emanuela, Aieta, Michele, Conteduca, Vincenza, Maines, Francesca, Bianchi, Emanuela, Massari, Francesco, Veccia, Antonello, Chiuri, Vincenzo E., Facchini, Gaetano, De Giorgi, Ugo
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2016
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5062111/
https://ncbi.nlm.nih.gov/pubmed/27790145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00376
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki